Get startedLog in
    Picture of Yichang Hec Changjiang Pharmaceutical Co logo

    1558 — Yichang Hec Changjiang Pharmaceutical Co News Story

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareSpeculativeMid Cap
    All News

    Brief: YiChang HEC Changjiang Pharmaceutical Says Sunshine Lake Pharma To Enter Licensing Agreement

    Picture of Yichang Hec Changjiang Pharmaceutical Co logoYichang Hec Changjiang Pharmaceutical Co
    12/11/2024 15:29
    Nov 12 (Reuters) - YiChang HEC ChangJiang Pharmaceutical
Co Ltd  1558.HK :
    * SUNSHINE LAKE PHARMA TO ENTER LICENSING AGREEMENT WITH
APOLLO
THERAPEUTICS
    * AGREEMENT TO DEVELOP AND COMMERCIALISE APL-18881
(HEC88473), A
FGF21 / GLP-1 DUAL RECEPTOR AGONIST


Further company coverage:  1558.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Yichang Hec Changjiang Pharmaceutical Co

    See all news